Literature DB >> 9627658

Patterns of visual field progression in patients with retinitis pigmentosa.

S Grover1, G A Fishman, J Brown.   

Abstract

OBJECTIVE: The purpose of the study was to determine whether distinct patterns of visual field progression are present in patients with retinitis pigmentosa (RP) and to evaluate the correlation between these patterns, if present, and different genetic subtypes of RP.
DESIGN: A retrospective analysis of patterns of visual field progression in RP was performed. PARTICIPANTS: Visual fields of 162 patients with RP, including 55 with type 2 Usher syndrome, who had at least 3 Goldmann visual field examinations during a period of at least 3 years were reviewed. MAIN OUTCOME MEASURES: Goldmann visual fields.
RESULTS: Visual fields of 86 patients could be classified into one of three specific patterns of visual field progression. Pattern I included those patients with a progressive concentric loss of visual fields; pattern II included those with visual field loss that began superiorly and subsequently developed an arcuate scotoma that progressed either from the nasal (IIA) or the temporal (IIB and IIC) side; and pattern III included patients whose visual field loss was characterized initially by a complete or incomplete midperipheral "ring scotoma" that broke through into the periphery. The end stage of all these patterns was a residual central visual field, sometimes also associated with a small peripheral island. In 53 of the 162 patients, the pattern of visual field loss could not be categorized because of an advanced stage of field loss at the time of the initial examination.
CONCLUSIONS: Distinctive patterns of visual field progression can be observed in patients with retinitis pigmentosa and type 2 Usher syndrome. There were no intrafamilial variations in the pattern of visual field loss in our data on 24 patients from 11 families. Within certain genetic subtypes, there was a predilection for a preponderance of a specific pattern of visual field progression. Future studies may be able to correlate these patterns of visual field loss with different genetic mutations. A greater understanding as to why certain patterns of field loss exist could potentially provide greater insight into the various pathogenetic mechanism(s) by which photoreceptor cells degenerate in this group of patients.

Entities:  

Mesh:

Year:  1998        PMID: 9627658     DOI: 10.1016/S0161-6420(98)96009-2

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  35 in total

1.  Evaluation of kinetic programs in various automated perimeters.

Authors:  Shigeki Hashimoto; Chota Matsumoto; Mariko Eura; Sachiko Okuyama; Yoshikazu Shimomura
Journal:  Jpn J Ophthalmol       Date:  2017-04-25       Impact factor: 2.447

2.  Reduced Central Retinal Artery Blood Flow Is Related to Impaired Central Visual Function in Retinitis Pigmentosa Patients.

Authors:  Samantha Kayser; Patricia Vargas; Deborah Mendelsohn; Jorge Han; Hua Bi; Alexandra Benavente; Ava K Bittner
Journal:  Curr Eye Res       Date:  2017-09-14       Impact factor: 2.424

3.  Molecular Heterogeneity Within the Clinical Diagnosis of Pericentral Retinal Degeneration.

Authors:  Rodrigo Matsui; Artur V Cideciyan; Sharon B Schwartz; Alexander Sumaroka; Alejandro J Roman; Malgorzata Swider; Wei Chieh Huang; Rebecca Sheplock; Samuel G Jacobson
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-09       Impact factor: 4.799

4.  Autosomal recessive retinitis pigmentosa caused by mutations in the MAK gene.

Authors:  Edwin M Stone; Xunda Luo; Elise Héon; Byron L Lam; Richard G Weleber; Jennifer A Halder; Louisa M Affatigato; Jacqueline B Goldberg; Alexander Sumaroka; Sharon B Schwartz; Artur V Cideciyan; Samuel G Jacobson
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-12-28       Impact factor: 4.799

5.  Spectral-domain optical coherence tomography measures of outer segment layer progression in patients with X-linked retinitis pigmentosa.

Authors:  David G Birch; Kirsten G Locke; Yuquan Wen; Kelly I Locke; Dennis R Hoffman; Donald C Hood
Journal:  JAMA Ophthalmol       Date:  2013-09       Impact factor: 7.389

6.  Longitudinal and cross-sectional study of patients with early-onset severe retinal dystrophy associated with RPE65 mutations.

Authors:  Karina Paunescu; Bettina Wabbels; Markus N Preising; Birgit Lorenz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-11-24       Impact factor: 3.117

7.  Multimodal Imaging of Central Retinal Disease Progression in a 2-Year Mean Follow-up of Retinitis Pigmentosa.

Authors:  Tharikarn Sujirakul; Michael K Lin; Jimmy Duong; Ying Wei; Sara Lopez-Pintado; Stephen H Tsang
Journal:  Am J Ophthalmol       Date:  2015-07-09       Impact factor: 5.258

8.  Self-reported quality of life in patients with retinitis pigmentosa and maculopathy of Bothnia type.

Authors:  Marie S I Burstedt; Eva Mönestam
Journal:  Clin Ophthalmol       Date:  2010-03-24

9.  Phenotypic conservation in patients with X-linked retinitis pigmentosa caused by RPGR mutations.

Authors:  Sarwar Zahid; Naheed Khan; Kari Branham; Mohammad Othman; Athanasios J Karoukis; Nisha Sharma; Ashley Moncrief; Mahdi N Mahmood; Paul A Sieving; Anand Swaroop; John R Heckenlively; Thiran Jayasundera
Journal:  JAMA Ophthalmol       Date:  2013-08       Impact factor: 7.389

10.  Defining the residual vision in leber congenital amaurosis caused by RPE65 mutations.

Authors:  Samuel G Jacobson; Tomas S Aleman; Artur V Cideciyan; Alejandro J Roman; Alexander Sumaroka; Elizabeth A M Windsor; Sharon B Schwartz; Elise Heon; Edwin M Stone
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-12-30       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.